In the last three years we have received funding from:

  • Queensland Health Advance Fellowship to determine utility of ctDNA for precision medicine in BRAF wild type Stage III and IV melanoma
  • Princess Alexandra Hospital Program Grant for Cancer Evolution Biobank
  • NHMRC Development Grant with Dr Barbara Rolfe (UQ) regarding the role of Complement C3a and neutrophils in melanoma
  • ASSC Grant with Dr Jason Lee (QIMR Berghofer) investigating the role of cholesterol on melanoma
  • PdCCRS investigationg radiomics as biomarkers for genomic subgroups and survival in melanoma
  • NHMRC Project Grant with Dr Nic Waddell (QIMR Berghofer) whole genome sequencing study of patient samples obtained from DOCTOR trial
  • MRFF MASTERPLAN clinical trial of chemotherapy and stereotactic radiation for pancreatic cancer
  • SERTA Grant investigating T cell response to tumour neoantigens in long term surivors of oesophageal cancer
  • Avner Foundation with Dr John Hooper Theranostic biomolecules for improved diagnosis and treatment of pancreatic cancer.
  • Roche Diagnostics ctDNA: Towards biomarkers of progression and prognosis in Oesophageal Cancer